SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 167 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 21.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $84,964 | +27.9% | 88,504 | -0.1% | 0.00% | – |
| Q1 2023 | $66,434 | +103.5% | 88,579 | 0.0% | 0.00% | – |
| Q4 2022 | $32,641 | -14.1% | 88,579 | -0.1% | 0.00% | – |
| Q3 2022 | $38,000 | -44.9% | 88,662 | +1.0% | 0.00% | – |
| Q2 2022 | $69,000 | -89.2% | 87,751 | -82.3% | 0.00% | – |
| Q1 2022 | $640,000 | -62.6% | 496,150 | -63.2% | 0.00% | – |
| Q4 2021 | $1,710,000 | -42.9% | 1,347,653 | -1.9% | 0.00% | -100.0% |
| Q3 2021 | $2,994,000 | -39.2% | 1,373,688 | +4.6% | 0.00% | 0.0% |
| Q2 2021 | $4,923,000 | +3.9% | 1,313,019 | -9.7% | 0.00% | 0.0% |
| Q1 2021 | $4,740,000 | -8.3% | 1,453,890 | -4.1% | 0.00% | 0.0% |
| Q4 2020 | $5,168,000 | -15.6% | 1,515,338 | +1.0% | 0.00% | -50.0% |
| Q3 2020 | $6,123,000 | +44.5% | 1,500,686 | +19.7% | 0.00% | +100.0% |
| Q2 2020 | $4,238,000 | +53.1% | 1,253,849 | +5.5% | 0.00% | 0.0% |
| Q1 2020 | $2,769,000 | -39.7% | 1,188,763 | -5.8% | 0.00% | 0.0% |
| Q4 2019 | $4,594,000 | -54.5% | 1,262,018 | +3.8% | 0.00% | -66.7% |
| Q3 2019 | $10,089,000 | -3.2% | 1,216,331 | +0.4% | 0.00% | 0.0% |
| Q2 2019 | $10,426,000 | -18.0% | 1,210,987 | +1.8% | 0.00% | -25.0% |
| Q1 2019 | $12,714,000 | +25.8% | 1,189,260 | +3.0% | 0.00% | +33.3% |
| Q4 2018 | $10,103,000 | -48.0% | 1,154,661 | -0.1% | 0.00% | -40.0% |
| Q3 2018 | $19,423,000 | -16.2% | 1,156,085 | +4.5% | 0.01% | -16.7% |
| Q2 2018 | $23,180,000 | +34.4% | 1,105,928 | +3.2% | 0.01% | +20.0% |
| Q1 2018 | $17,246,000 | -13.2% | 1,071,858 | +2.2% | 0.01% | 0.0% |
| Q4 2017 | $19,877,000 | +53.7% | 1,048,890 | +14.1% | 0.01% | +25.0% |
| Q3 2017 | $12,935,000 | +94.3% | 919,334 | +2.9% | 0.00% | +100.0% |
| Q2 2017 | $6,658,000 | +6.9% | 893,692 | -6.7% | 0.00% | 0.0% |
| Q1 2017 | $6,227,000 | +51.9% | 958,006 | +3.5% | 0.00% | +100.0% |
| Q4 2016 | $4,099,000 | +3.3% | 925,529 | +9.0% | 0.00% | 0.0% |
| Q3 2016 | $3,967,000 | -21.9% | 849,335 | +9.8% | 0.00% | -50.0% |
| Q2 2016 | $5,080,000 | -0.5% | 773,223 | -3.6% | 0.00% | 0.0% |
| Q1 2016 | $5,103,000 | +7.3% | 802,311 | +1.7% | 0.00% | +100.0% |
| Q4 2015 | $4,758,000 | -0.1% | 789,020 | -0.9% | 0.00% | 0.0% |
| Q3 2015 | $4,761,000 | -0.1% | 796,066 | +14.3% | 0.00% | 0.0% |
| Q2 2015 | $4,764,000 | +30.7% | 696,355 | +16.0% | 0.00% | 0.0% |
| Q1 2015 | $3,644,000 | -10.3% | 600,223 | +2.4% | 0.00% | 0.0% |
| Q4 2014 | $4,061,000 | -16.3% | 586,043 | -1.7% | 0.00% | 0.0% |
| Q3 2014 | $4,854,000 | -47.1% | 596,260 | -47.2% | 0.00% | 0.0% |
| Q2 2014 | $9,184,000 | +111.0% | 1,129,848 | +103.5% | 0.00% | 0.0% |
| Q1 2014 | $4,353,000 | -13.3% | 555,265 | -2.2% | 0.00% | 0.0% |
| Q4 2013 | $5,022,000 | -51.1% | 567,487 | -53.7% | 0.00% | -50.0% |
| Q3 2013 | $10,272,000 | +133.0% | 1,225,732 | +107.4% | 0.00% | +100.0% |
| Q2 2013 | $4,408,000 | – | 591,025 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
| Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
| Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
| Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
| ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
| PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
| Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
| PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
| J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |